Correlation Between Lexicon Pharmaceuticals and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Lexicon Pharmaceuticals and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexicon Pharmaceuticals and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexicon Pharmaceuticals and Mereo BioPharma Group, you can compare the effects of market volatilities on Lexicon Pharmaceuticals and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexicon Pharmaceuticals with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexicon Pharmaceuticals and Mereo BioPharma.
Diversification Opportunities for Lexicon Pharmaceuticals and Mereo BioPharma
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lexicon and Mereo is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Lexicon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexicon Pharmaceuticals are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Lexicon Pharmaceuticals i.e., Lexicon Pharmaceuticals and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Lexicon Pharmaceuticals and Mereo BioPharma
Given the investment horizon of 90 days Lexicon Pharmaceuticals is expected to under-perform the Mereo BioPharma. In addition to that, Lexicon Pharmaceuticals is 2.43 times more volatile than Mereo BioPharma Group. It trades about -0.34 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.24 per unit of volatility. If you would invest 420.00 in Mereo BioPharma Group on August 28, 2024 and sell it today you would lose (82.00) from holding Mereo BioPharma Group or give up 19.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lexicon Pharmaceuticals vs. Mereo BioPharma Group
Performance |
| Timeline |
| Lexicon Pharmaceuticals |
| Mereo BioPharma Group |
Lexicon Pharmaceuticals and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lexicon Pharmaceuticals and Mereo BioPharma
The main advantage of trading using opposite Lexicon Pharmaceuticals and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexicon Pharmaceuticals position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
| Mereo BioPharma vs. Eliem Therapeutics | Mereo BioPharma vs. HCW Biologics | Mereo BioPharma vs. Scpharmaceuticals | Mereo BioPharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |